The search for new antimicrobial agents from the substituted arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids

Authors

  • K. Yu. Krolenko National University of Pharmacy, Ukraine
  • S. V. Vlasov National University of Pharmacy, Ukraine
  • I. O. Zhuravel National University of Pharmacy, Ukraine
  • T. P. Osolodchenko State Institution “Institute of Microbiology and Immunology named after I.I.Mechnikov of the National, Ukraine

DOI:

https://doi.org/10.24959/ophcj.16.877

Keywords:

quinazoline, piperidine, ureas, antimicrobials

Abstract

The methods for the synthesis of the substituted arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids using the technologies of the liquid-phase parallel synthesis have been developed. The structure of the compounds obtained has been confi rmed by the data of the instrumental methods of organic analysis. The antibacterial activity of the compounds obtained has been studied using the agar “well” diffusion method against the standard test-strains of microorganisms. The results of the screening performed have shown that all compounds inhibit the growth of Staphylococcus aureus and Bacillus subtilis strains. The strains of Proteus vulgaris and Pseudomonas aeruginosa have been found to be the most resistant. The SAR-analysis of the substituted arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids has demonstrated that the presence of the electron-donating substituents in position 8 of the quinazolin-4-one cycle and in position 4 of the aromatic fragment of the urea increases the activity of the compounds of this series against gram-positive bacteria. Such high effi cacy of the lead compounds against the gram-positive bacterial strains can be applied for creating the narrow spectrum antibiotics derived from arylamides of 4-(4-oxo-4H-quinazolin-3-yl)-piperidine-1-carboxylic acids.

Downloads

Download data is not yet available.

References

  1. Пат. WO2006/117762 (2007). Заявл.: 03.05.2006. Опубл.: 08.02.2007. [Электронный ресурс]. Режим доступа http://worldwide.espacenet.com/
  2. publicationDetails/originalDocument?CC=WO&NR=2006117762A3&KC=A3&FT=D&ND=&date=20070208&DB=&&locale=en_EP.
  3. Пат. US20130090326 (2013). Заявл.: 15.10.2010. Опубл.: 11.04.2013. [Электронный ресурс]. Режим доступа http://worldwide.espacenet.com/
  4. publicationDetails/originalDocument?CC=US&NR=2013090326A1&KC=A1&FT=D&ND=&date=20130411&DB=&&locale=en_EP.
  5. Samala G., Devi P. B., Nallangi R., Sridevi J. P., Saxena S., Yogeeswari P., Sriram D. Biorg. Med. Chem., 2014, Vol. 22, No.6, pp.1938-1947.
  7. Zheng P., Somersan-Karakaya S., Lu S., Roberts J., Pingle M., Warrier T., Little D., Guo X., Brickner S. J., Nathan C. F. J. Med. Chem., 2014, Vol. 57, No.9,
  8. pp. 3755-3772.
  9. Пат. WO2010103381 (2010). Заявл.: 10.03.2010. Опубл.: 16.09.2010. [Электронный ресурс]. Режим доступа http://worldwide.espacenet.com/
  10. publicationDetails/originalDocument?CC=WO&NR=2010103381A1&KC=A1&FT=D&ND=&date=20100916&DB=&&locale=en_EP.
  11. Christodoulou M. S., Fokialakis N., Passarella D., García-Argáez A. N., Gia O. M., Pongratz I., Dalla Via L., Haroutounian S. A. Biorg. Med. Chem., 2013,
  12. Vol. 21, No.14, pp. 4120-4131.
  13. Пат. US8691993 (2014). Заявл.: 06.12.2012. Опубл.: 08.04.2014. [Электронный ресурс]. Режим доступа http://worldwide.espacenet.com/
  14. publicationDetails/originalDocument?CC=US&NR=8691993B2&KC=B2&FT=D&ND=&date=20140408&DB=&&locale=en_EP.
  15. Пат. WO2012087938 (2012). Заявл.: 19.12.2011. Опубл.: 28.06.2012. [Электронный ресурс]. Режим доступа https://patentscope.wipo.int/
  16. search/en/detail.jsf?docId=WO2012087938.
  17. Власов С. В., Кроленко К. Ю., Журавель И. А., Коваленко С. Н. Вестник КазНМУ, 2015, No.3, pp.232-236.
  18. Chikkulapalli A., Aavula S. K., Mona N. P. R., Karthikeyan C., Vinodh Kumar C. H., Sulur G. M., Sumathi, S. Tetrahedron Lett., 2015, Vol. 56, No.24, pp.3799-3803.
  19. Anandan S.-K., Gless R. D. Bioorg. Med. Chem. Lett., 2010, Vol. 20, No.9, pp.2740-2744.
  20. Kołaczek A., Fusiarz I., Ławecka J., Branowska D. CHEMIK, 2014, Vol. 68, No.7, pp.620-628.
  21. Bhattacharyya S., Pathak U., Mathur S., Vishnoi S., Jain R. RSC Adv., 2014, Vol. 4, No.35, pp.18229-18233.
  22. Chaturvedi D. Tetrahedron, 2012, Vol, 68, No.1, pp.15-45.
  23. American Society for Microbiology, Coyle M.B. Manual of Antimicrobial Susceptibility Testing. American Society for Microbiology: Washington, 2005, p.236.
  24. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. Document M100-S22, 2012, Vol. 32, No.3, CLSI, Wayne, PA, January.
  25. McFarland J. Journal of the American Medical Association, 1907, Vol. 49, No.14, pp.1176-1178.

Downloads

Published

2016-03-04

How to Cite

(1)
Krolenko, K. Y.; Vlasov, S. V.; Zhuravel, I. O.; Osolodchenko, T. P. The Search for New Antimicrobial Agents from the Substituted Arylamides of 4-(4-Oxo-4H-Quinazolin-3-Yl)-Piperidine-1-Carboxylic Acids. J. Org. Pharm. Chem. 2016, 14, 17-23.

Issue

Vol. 14 No. 1(53) (2016)

Section

Original Researches

License

Copyright (c) 2016 National University of Pharmacy

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:

1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.

3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).